Table 3.
STDs | Model | Modeling performance | Predicting performance | ||||
---|---|---|---|---|---|---|---|
MAE | RMSE | MAPE (%) | MAE | RMSE | MAPE (%) | ||
AIDS | ARIMA | 0.04/0.05 | 0.05/0.03 | 12.00/11.87 | 0.08/0.05 | 0.09/0.05 | 23.26/12.86 |
ERNN | 0.04/0.04 | 0.05/0.05 | 12.36/14.42 | 0.07/0.09 | 0.08/0.11 | 20.24//23.54 | |
ARIMA-ERNN | 0.03/0.03 | 0.04/0.04 | 11.00/9.72 | 0.06/0.06 | 0.08/0.07 | 18.34/14.74 | |
LSTM | 0.07/0.03 | 0.09/0.04 | 23.39/11.00 | 0.06/0.08 | 0.07/0.11 | 18.63/25.43 | |
Gonorrhea | ARIMA | 0.04/0.04 | 0.06/0.03 | 7.25/5.08 | 0.14/0.13 | 0.19/0.10 | 19.44/17.07 |
ERNN | 0.05/0.05 | 0.07/0.06 | 8.50/8.23 | 0.14/0.12 | 0.19/0.14 | 18.03/17.95 | |
ARIMA-ERNN | 0.04/0.03 | 0.06/0.04 | 6.75/4.98 | 0.13/0.10 | 0.17/0.13 | 17.77/16.46 | |
LSTM | 0.01/0.33 | 0.02/0.06 | 1.38/5.95 | 0.04/0.09 | 0.05/0.12 | 5.09/15.13 | |
Syphilis | ARIMA | 0.16/0.18 | 0.25/0.14 | 6.15/5.40 | 0.29/0.78 | 0.39/0.71 | 9.80/21.88 |
ERNN | 0.18/0.26 | 0.25/0.30 | 6.775/9.744 | 0.30/0.78 | 0.13/0.87 | 9.55/24.00 | |
ARIMA-ERNN | 0.16/0.12 | 0.24/0.16 | 6.079/4.605 | 0.26/0.66 | 0.35/0.72 | 8.67/20.18 | |
LSTM | 0.23/0.21 | 0.12/0.31 | 8.571/8.932 | 0.17/0.35 | 0.25/0.44 | 5.79/11.20 |
aOne-year forecast performance/5-year forecast performance.